Literature DB >> 11779892

Basilar vasospasm diagnosis: investigation of a modified "Lindegaard Index" based on imaging studies and blood velocity measurements of the basilar artery.

Jean F Soustiel1, Venyamin Shik, Reuven Shreiber, Yonit Tavor, Dorith Goldsher.   

Abstract

BACKGROUND AND
PURPOSE: Numerous studies have shown that cerebral vasospasm is one of the leading causes of death and neurological disability after subarachnoid hemorrhage. Most of these studies, however, have focused on anterior circulation vessels. Since the introduction of the transcranial Doppler (TCD), increasing attention has been given to basilar artery (BA) vasospasm, especially in traumatic subarachnoid hemorrhage. As shown for the anterior circulation, however, the significance of elevated flow velocities (FVs) in the posterior vessels may be ambiguous, so vasospasm may not be reliably differentiated from hyperemia. The purpose of the present study was to evaluate the potential additional value of an intracranial/extracranial FV ratio in the posterior circulation to cope with this shortcoming of the TCD in the diagnosis of BA vasospasm.
METHODS: FV in the extracranial vertebral artery (VA) was measured in 20 healthy volunteers. Normative values of an intracranial/extracranial VA FV ratio (IVA/EVA) and a BA/extracranial VA FV ratio (BA/EVA) were calculated. Thirty-four patients with subarachnoid hemorrhage were then evaluated with TCD and CT angiography (CTA). The value of the IVA/EVA and BA/EVA ratios in the diagnosis and assessment of vertebrobasilar vasospasm was investigated.
RESULTS: The extracranial VA could be insonated in all subjects at depths ranging from 45 to 55 mm. The average FV for the extracranial VA was 26 cm/s. The ratios between intracranial and extracranial VA FVs were 1.6 on both sides, whereas the ratio between the BA FVs and the mean extracranial VA FVs was slightly higher at 1.7. Fourteen patients (41.2%) had CTA evidence of BA vasospasm. Vasospasm was severe in 7 patients, moderate in 1, and mild in the remaining. An FV threshold of 80 cm/s was indicative of BA vasospasm in 92.8% with 3 false-positive results that could be related to vertebrobasilar hyperemia. Comparative analysis between CTA and TCD findings showed that BA/EVA was >2 in all patients with BA vasospasm (100% sensitivity) and < 2 in all but 1 patient without BA vasospasm (95% specificity). Furthermore, the BA/EVA ratio showed a close correlation with BA diameter (r=-0.8139, P<0.0001) and was >3 in all patients with severe vasospasm.
CONCLUSIONS: The results of the present study showed that the BA/EVA ratio may contribute to an improved discrimination between BA vasospasm and vertebrobasilar hyperemia and enhance the accuracy and reliability of TCD in the diagnosis of BA vasospasm. Our data further suggest that the BA/EVA ratio may provide an approximation of vasospasm severity and help in identifying patients who are likely to suffer from hemodynamically significant vasospasm.

Entities:  

Mesh:

Year:  2002        PMID: 11779892     DOI: 10.1161/hs0102.100484

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

Review 1.  Applications of transcranial Doppler in the ICU: a review.

Authors:  Hayden White; Balasubramanian Venkatesh
Journal:  Intensive Care Med       Date:  2006-05-10       Impact factor: 17.440

2.  Vasospasm after subarachnoid hemorrhage: utility of perfusion CT and CT angiography on diagnosis and management.

Authors:  M Wintermark; N U Ko; W S Smith; S Liu; R T Higashida; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

Review 3.  Posttraumatic vasospasm detected by continuous brain tissue oxygen monitoring: treatment with intraarterial verapamil and balloon angioplasty.

Authors:  Kiarash Shahlaie; James E Boggan; Richard E Latchaw; Cheng Ji; J Paul Muizelaar
Journal:  Neurocrit Care       Date:  2008-09-20       Impact factor: 3.210

4.  Small vessel disease in patients with subarachnoid hemorrhage: Prevalence and associations with vasospasm occurrence, severity and clinical outcomes.

Authors:  Adrien Villain; Grégoire Boulouis; Wagih Ben Hassen; Christine Rodriguez-Regent; Denis Trystram; Myriam Edjlali; François Nataf; Xavier Sauvageon; Tarek Sharshar; Jean F Meder; Catherine Oppenheim; Olivier Naggara
Journal:  Neuroradiol J       Date:  2019-09-30

Review 5.  Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature.

Authors:  Chad W Washington; Gregory J Zipfel
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

6.  Role of multisection CT angiography in the evaluation of vertebrobasilar vasospasm in patients with subarachnoid hemorrhage.

Authors:  Dorith Goldsher; Reuven Shreiber; Venyamin Shik; Yonit Tavor; Jean F Soustiel
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

7.  Quantitative comparison of hemodynamics in simulated and 3D angiography models of cerebral aneurysms by use of computational fluid dynamics.

Authors:  Tatsunori Saho; Hideo Onishi
Journal:  Radiol Phys Technol       Date:  2015-04-25

8.  Milrinone as a rescue therapy for symptomatic refractory cerebral vasospasm in aneurysmal subarachnoid hemorrhage.

Authors:  C M Romero; D Morales; A Reccius; F Mena; J Prieto; P Bustos; J Larrondo; J Castro
Journal:  Neurocrit Care       Date:  2009       Impact factor: 3.210

Review 9.  Cerebral blood flow and autoregulation after pediatric traumatic brain injury.

Authors:  Yuthana Udomphorn; William M Armstead; Monica S Vavilala
Journal:  Pediatr Neurol       Date:  2008-04       Impact factor: 3.372

10.  High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: an open-label feasibility study.

Authors:  Raul G Nogueira; Michael J Bodock; Walter J Koroshetz; Mehmet A Topcuoglu; Bob S Carter; Christopher S Ogilvy; Johnny C Pryor; Ferdinando S Buonanno
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.